NASDAQ:INCR

InterCure (INCR) Stock Price, News & Analysis

$2.66
+0.02 (+0.76%)
(As of 04/26/2024 ET)
Today's Range
$2.61
$2.70
50-Day Range
$1.75
$2.72
52-Week Range
$0.99
$2.92
Volume
11,841 shs
Average Volume
78,908 shs
Market Capitalization
$121.22 million
P/E Ratio
20.46
Dividend Yield
N/A
Price Target
N/A
INCR stock logo

About InterCure Stock (NASDAQ:INCR)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

INCR Stock Price History

INCR Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
InterCure Provides an Update Regarding Nir Oz Facility
InterCure Provides an Update Regarding Nir Oz Facility
Intrakat Technikon Kai Energeiakon Ergon AE (INCr)
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
INCR_t3 Historical Data
Intercure Ltd INCR
Closing Bell: Intercure Ltd up on Monday (INCR-U)
Closing Bell: Intercure Ltd down on Monday (INCR-U)
Closing Bell: Intercure Ltd flat on Monday (INCR-U)
See More Headlines
Receive INCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/26/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:INCR
Fax
N/A
Employees
370
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$115.83 million
Cash Flow
$0.39 per share
Book Value
$3.64 per share

Miscellaneous

Free Float
45,464,000
Market Cap
$121.22 million
Optionable
Optionable
Beta
1.73
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Alexander Rabinovich (Age 53)
    CEO & Director
    Comp: $500k
  • Mr. Amos Cohen (Age 45)
    Chief Financial Officer
    Comp: $848k
  • Einat Zehavi
    Vice President of Sales
  • Mr. Omri Batzir
    Corporate Controller

INCR Stock Analysis - Frequently Asked Questions

How have INCR shares performed in 2024?

InterCure's stock was trading at $1.2898 on January 1st, 2024. Since then, INCR stock has increased by 106.2% and is now trading at $2.66.
View the best growth stocks for 2024 here
.

Are investors shorting InterCure?

InterCure saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 56,200 shares, a decline of 37.7% from the March 31st total of 90,200 shares. Based on an average daily volume of 90,200 shares, the short-interest ratio is presently 0.6 days. Currently, 0.2% of the company's stock are sold short.
View InterCure's Short Interest
.

When is InterCure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our INCR earnings forecast
.

How do I buy shares of InterCure?

Shares of INCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:INCR) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners